Skip to main content

ORIGINAL RESEARCH article

Front. Cell Dev. Biol.
Sec. Cell Adhesion and Migration
Volume 12 - 2024 | doi: 10.3389/fcell.2024.1435708
This article is part of the Research Topic Editors' Showcase 2023: Insights in Cell Adhesion and Migration View all 6 articles

Three-dimensional cell culture conditions promoted Mesenchymal-Amoeboid Transition in the Triple-Negative Breast Cancer line, MDA-MB-231

Provisionally accepted
  • 1 Medical Research Unit in Reproductive Medicine, Mexican Social Security Institute, Mexico City, Mexico
  • 2 Biomedical Imaging Group, Swiss Federal Institute of Technology Lausanne, Lausanne, Vaud, Switzerland
  • 3 Bioimage Analysis Unit, Institut Pasteur, Paris, Île-de-France, France
  • 4 CNRS UMR3691, Centre National de la Recherche Scientifique (CNRS), Paris, France
  • 5 Microscopy Core Unit, Institute of Cellular Physiology, National Autonomous University of Mexico, Mexico City, México, Mexico
  • 6 Engineering and Natural Science Doctoral Program and Department of Natural Science, Metropolitan Autonomous University, Cuajimalpa de Morelos, México, Mexico
  • 7 CNRS ERL9195, Centre National de la Recherche Scientifique (CNRS), Paris, France
  • 8 Medical Research Unit in Reproductive Medicine,, Mexican Social Security Institute, Mexico City, Mexico

The final, formatted version of the article will be published soon.

    Breast cancer (BC) is the leading cause of death among women, primarily due to its potential for metastasis. As BC progresses, the extracellular matrix (ECM) produces more type-I collagen, resulting in increased stiffness. This alteration influences cellular behaviors such as migration, invasion, and metastasis. Specifically, cancer cells undergo changes in gene expression that initially promote an epithelial-to-mesenchymal transition (EMT) and subsequently, a transition from a mesenchymal to an amoeboid (MAT) migration mode. In this way, cancer cells can migrate more easily through the stiffer microenvironment. Despite their importance, understanding MATs remains challenging due to the difficulty of replicating in vitro the conditions for cell migration that are observed in vivo. To address this challenge, we developed a three-dimensional (3D) growth system that replicates the different matrix properties observed during the progression of a breast tumor. We used this model to study the migration and invasion of the Triple-Negative BC (TNBC) cell line MDA-MB-231, which is particularly subject to metastasis. Our results indicate that denser collagen matrices present a reduction in porosity, collagen fiber size, and collagen fiber orientation, which are associated with the transition of cells to a rounder morphology with bleb-like protrusions. We quantified how this transition is associated with a more persistent migration, an enhanced invasion capacity, and a reduced secretion of matrix metalloproteinases. Our findings suggest that the proposed 3D growth conditions (especially those with high collagen concentrations) mimic key features of MATs, providing a new platform to study the physiology of migratory transitions and their role in BC progression.

    Keywords: breast cancer, three-dimensional (3D) growth conditions, Epithelialmesenchymal transition (EMT), mesenchymal-amoeboid transition (MAT), metastasis Methodology, Aleix Boquet-Pujadas: Methodology, Writing -original draft, writing -review & editing

    Received: 20 May 2024; Accepted: 17 Jul 2024.

    Copyright: © 2024 Rodriguez-Cruz, Boquet-Pujadas, López—Muñoz, Rincón- Heredia, Paredes-Díaz, Flores-Fortis, Olivo-Marin, Guillen and Aguilar-Rojas. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Arturo Aguilar-Rojas, Medical Research Unit in Reproductive Medicine,, Mexican Social Security Institute, Mexico City, Mexico

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.